ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,456Medicare Part D Prescriptions Filled, Including Refills

Rank: 57 out of 2343

$1.13M Total Retail Price of All Prescriptions

Rank: 81 out of 2343

545 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 545 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

12% of this provider’s 545 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 16,535 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LEVOTHYROXINE SODIUM 803 605 1 2
SIMVASTATIN 770 576 2 1
OMEPRAZOLE 680 498 3 4
METOPROLOL TARTRATE 604 456 4 7
BUMETANIDE 501 447 5 91
POTASSIUM CHLORIDE 480 391 6 18
FUROSEMIDE 458 345 7 6
ISOSORBIDE MONONITRATE ER 452 417 8 32
AMLODIPINE BESYLATE 391 334 9 5
METOPROLOL SUCCINATE 378 316 10 14
DONEPEZIL HCL 361 328 11 21
WARFARIN SODIUM 308 306 12 8
CARVEDILOL 305 271 13 27
PRAVASTATIN SODIUM 299 227 14 15
BENAZEPRIL HCL 295 250 15 113
DIGOXIN 288 283 16 35
ATORVASTATIN CALCIUM 230 184 17 10
HYDROCODONE-ACETAMINOPHEN 229 114 S3 18 13
CLOPIDOGREL 223 200 19 26
NAMENDA 222 215 20 36
METFORMIN HCL 217 176 21 9
LISINOPRIL 211 160 22 3
OXYCODONE-ACETAMINOPHEN 193 142 S2 23 49
CITALOPRAM HBR 177 123 24 17
TAMSULOSIN HCL 176 150 25 29
FENTANYL 171 140 S2 26 69
PANTOPRAZOLE SODIUM 169 127 27 22
DILTIAZEM 24HR CD 167 141 28 83
SERTRALINE HCL 167 126 28 20
RAMIPRIL 166 157 30 90
GABAPENTIN 158 122 31 16
DIOVAN HCT 154 154 32 63
PREDNISONE 153 121 33 37
KLOR-CON M10 150 119 34 107
RANITIDINE HCL 148 92 35 43
DIOVAN 148 121 35 23
AZITHROMYCIN 143 99 37 39
PLAVIX 134 121 38 38
LOSARTAN-HYDROCHLOROTHIAZIDE 131 113 39 64
ZOLPIDEM TARTRATE 129 86 40 24
LABETALOL HCL 128 124 41 153
ESCITALOPRAM OXALATE 127 96 42 55
RISPERIDONE 124 48 43 61
ENALAPRIL MALEATE 121 108 44 58
ALLOPURINOL 121 120 44 31
SPIRIVA 112 81 46 48
INSULIN SYRINGE 111 50 47 102
AMLODIPINE BESYLATE-BENAZEPRIL 107 107 48 59
SOTALOL 106 96 49 177
DILTIAZEM 24HR ER 106 94 49 76
ATENOLOL 104 78 51 12
LIPITOR 102 81 52 78
SYNTHROID 102 102 52 40
CRESTOR 101 86 54 30
BENAZEPRIL-HYDROCHLOROTHIAZIDE 100 68 55 343
OXYCONTIN 99 81 S2 56 138
PROAIR HFA 97 48 57 86
QUETIAPINE FUMARATE 96 45 58 77
NEXIUM 95 83 59 33
ADVAIR DISKUS 92 58 60 34
TRAMADOL HCL 87 35 61 25
DIVALPROEX SODIUM 86 37 62 105
CYMBALTA 86 70 62 74
NOVOLOG 86 46 62 110
LANTUS 84 56 65 51
AMIODARONE HCL 84 84 65 158
MELOXICAM 84 74 65 68
SPIRONOLACTONE 84 81 65 65
OXYCODONE HCL 80 23 S2 69 67
LACTULOSE 80 43 69 139
VERAPAMIL ER 78 78 71 95
FAMOTIDINE 78 63 71 60
LEVOFLOXACIN 78 60 71 106
VOLTAREN 77 73 74 175
CLONIDINE HCL 76 57 75 70
JANTOVEN 76 76 75 81
CLOTRIMAZOLE-BETAMETHASONE 74 60 77 127
VENLAFAXINE HCL ER 72 43 78 87
GLIPIZIDE XL 71 60 79 84
LOSARTAN POTASSIUM 71 65 79 19
VESICARE 68 35 81 145
BYSTOLIC 67 47 82 123
TORSEMIDE 67 67 82 157
CIPROFLOXACIN HCL 66 57 84 72
HYDROCHLOROTHIAZIDE 65 47 85 11
METOLAZONE 64 51 86 173
ENABLEX 64 64 86 319
PAROXETINE HCL 63 40 88 66
EXELON 62 62 89 129
AGGRENOX 61 61 90 174
POLYETHYLENE GLYCOL 3350 60 50 91 54
NOVOLOG MIX 70-30 FLEXPEN 60 55 91 335
ACETAMINOPHEN-CODEINE 58 23 S3 93 112
PHENYTOIN SODIUM EXTENDED 58 12 93 152
LISINOPRIL-HYDROCHLOROTHIAZIDE 58 42 93 42
DILTIAZEM ER 55 43 96 207
CELEBREX 54 53 97 71
BENICAR HCT 54 42 97 156
PREMARIN 54 30 R 97 286
GLIPIZIDE ER 54 54 97 115
ABILIFY 54 0 97 159
CARBIDOPA-LEVODOPA 53 53 102 85
OXYCODONE HCL-ACETAMINOPHEN 53 30 S2 102 136
FLUOXETINE HCL 52 26 104 82
GLYBURIDE-METFORMIN HCL 52 42 R 104 154
HUMALOG MIX 75-25 52 42 104 311
LEVEMIR 51 22 107 250
ACETAZOLAMIDE 51 38 107 486
BENZTROPINE MESYLATE 50 0 R 109 224
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 13, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.